VCYT
#1569
Veracyte, Inc. - Common Stock
44.2 6 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.38%
Monthly Change
-1.29%
6 month change
+25.67%
Year Change
+19.95%
Previous Close
44.8 8
Open
45.3 6
Low
44.2 4
High
45.9 9
Volume
141
Financials
- Market Capitalization 3.56 B
- Employee 755
- Founded 2006
- CEO N/A
- Website www.veracyte.com
- Headquarter Delaware, United States
- FIGI BBG001J2M542
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
41.95
Price to sales ratio
8.46
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1560 |  DNLI Denali Therapeutics Inc. - Common Stock | 22.85 USD | -1.80% | -5.70% | -2.97% | +41.31% | 3.65 B USD | ||
| 1564 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 82.30 USD | -0.56% | +17.62% | +33.45% | +24.58% | 3.61 B USD | ||
| 1599 |  ABCL AbCellera Biologics Inc. - Common Shares | 11.47 USD | +0.97% | -6.21% | +92.13% | +187.47% | 3.52 B USD | ||
| 1613 |  GPCR Structure Therapeutics Inc - American Depositary Shares | 47.06 USD | -1.55% | -3.07% | -4.74% | +75.99% | 3.36 B USD |
Frequently asked questions about Veracyte, Inc.
What is the Veracyte, Inc. stock price today?
The current price of Veracyte, Inc. (VCYT) is 44.26. Over the past 24 hours, the stock has changed by -1.38%. Follow the VCYT chart for real-time price dynamics.
What is the stock ticker of Veracyte, Inc.?
Veracyte, Inc. trades under the ticker VCYT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Veracyte, Inc. stock going up?
VCYT has changed by -0.87% over the last week, -1.29% over the last month, and +19.95% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Veracyte, Inc.?
Veracyte, Inc. currently has a market capitalization of 3.56 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Veracyte, Inc. earnings last quarter?
Last quarter, Veracyte, Inc. reported earnings of 0.32 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Veracyte, Inc. revenue for the last quarter?
Veracyte, Inc. reported quarterly revenue of 150.32 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Veracyte, Inc. net income for the last quarter?
Veracyte, Inc. reported net income of 25.49 M for the last quarter. The previous quarter showed 28.71 M, which means net income changed by -11.21%.
How many employees does Veracyte, Inc. have?
As of the latest available data, Veracyte, Inc. has 755 employees. Workforce size can provide additional context about the company's scale and operations.
What is Veracyte, Inc. EBITDA?
Veracyte, Inc. EBITDA is 69.59 M, and its EBITDA margin is 46.29%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Veracyte, Inc. stock?
You can buy Veracyte, Inc. (VCYT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Veracyte, Inc. stock?
Investing in Veracyte, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VCYT chart and related analysis on metatrader.com as part of your research.